Futura Medical plc (LON:FUM – Get Free Report)’s stock price fell 50.4% during mid-day trading on Thursday . The company traded as low as GBX 12 ($0.15) and last traded at GBX 15.37 ($0.19). 7,146,634 shares traded hands during mid-day trading, an increase of 1,069% from the average session volume of 611,389 shares. The stock had previously closed at GBX 31 ($0.39).
Futura Medical Stock Performance
The business has a 50 day moving average price of GBX 32.13 and a 200-day moving average price of GBX 34.17. The company has a market capitalization of £59.81 million, a price-to-earnings ratio of -1,978.00 and a beta of 1.25.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
See Also
- Five stocks we like better than Futura Medical
- What is Insider Trading? What You Can Learn from Insider Trading
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Steel Stocks Soaring After Tariff Announcements
- Most Volatile Stocks, What Investors Need to Know
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.